ArticleActa neuropathologica communications2022

Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation.

Nelli S Lakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.